Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of the ...
Cavazzoni was the head of the FDA’s Center for Drug Evaluation ... as the new secretary of Health and Human Services Department. At Pfizer, she will be an executive vice president and will ...
Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
However, when Trump introduced some of the dignitaries in attendance, Pfizer chief Albert Boula was not well received. 'We also have the head of Pfizer here so I want to thank him, one of the ...
Patrizia Cavazzoni, the FDA’s former head of drug regulation ... Bryan Supran, non-executive director and representative of Pfizer, stepped down from the Haleon board of directors. Elizabeth ...
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why PFE stock is a Buy.
Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback